Foot and Mouth Disease News and Research

RSS

Not serious enough to turn on the siren, toddler’s 39-mile ambulance ride still cost over $9,000

Elisabeth Yoder's son, Darragh, was 15 months old in August when he developed what at first looked to his parents like hand, foot, and mouth disease.

25 Nov 2025

New model reveals H5N1 is spreading undetected in US dairy herds

Researchers developed a nationwide model to simulate the spread of H5N1 in US dairy cattle, revealing significant under-reporting and predicting continued outbreaks into 2025. Targeted farm-level biosecurity and surveillance are urgently needed to contain the epidemic.

11 May 2025

New AI approach speeds up antiviral discovery for human enterovirus 71

Artificial intelligence algorithms have now been combined with traditional laboratory methods to uncover promising drug leads against human enterovirus 71 (EV71), the pathogen behind most cases of hand, foot and mouth disease.

6 May 2025

Machine learning uncovers promising drug leads against human enterovirus 71

Artificial intelligence algorithms have now been combined with traditional laboratory methods to uncover promising drug leads against human enterovirus 71 (EV71), the pathogen behind most cases of hand, foot and mouth disease.

29 Apr 2025

Innovative vaccine shields livestock from four strains of foot and mouth disease

A new vaccine, designed to protect East African cattle against all major strains of foot and mouth disease, is offering hope to small-scale farmers battling the highly contagious disease.

13 Nov 2024

Review highlights failures in global control strategies for bird flu transmission

A review of sustained mammal-to-mammal bird flu transmission in diverse species, led by The Pirbright Institute, shows global control strategies are not working.

24 Sep 2024

New research network focuses on high-priority viruses

The National Institutes of Health (NIH) has established a pandemic preparedness research network to conduct research on high-priority pathogens most likely to threaten human health with the goal of developing effective vaccines and monoclonal antibodies. Currently, many of the diseases caused by these pathogens have no available vaccines or therapeutics, and investing in this research is key to preparing for potential public health crises - both in the United States and around the world. NIH's National Institute of Allergy and Infectious Diseases (NIAID) expects to commit approximately $100 million per year to fund the program, pending the availability of funds.

14 Sep 2024

Study reveals impact of climate change on enterovirus outbreaks

Outbreaks of hand, foot and mouth disease (HFMD), which causes fever and rash in young children, typically occur in the summer months.

6 Aug 2024

Study demonstrates prolonged persistence of enteroviruses on commonly encountered surfaces

Hand, foot, and mouth disease (HFMD) is a contagious disease that mainly affects young children in the Asia-Pacific region.

23 Nov 2023

SOUND-control: A COST Action advancing cattle disease control in Europe

Europe has faced its fair share of animal health crises, like the outbreaks of Foot and Mouth Disease, Avian influenza in the Netherlands (2003), and African swine fever. But what about the diseases present in many countries that don't grab the headlines?

12 Jul 2023

Plant based compound peruvoside may be able to prevent up to 12 medically important viruses

Peruvoside, a plant-based compound that is commonly used to treat heart failure, has been discovered to be able to prevent up to 12 medically important viruses, all originating from different virus families.

22 Jun 2023

Could mRNA vaccines triumph over other viral infections in humans and domestic animals?

Researchers review potential areas for mRNA vaccine development against pathogenic viruses other than SARS-CoV-2.

28 Nov 2022

False positive monkeypox tests in low-risk patients with no exposures

Researchers reported three monkeypox diagnoses presenting atypical rashes.

13 Sep 2022

Hand, foot and mouth disease afflicting children hyped up as 'tomato flu'

Leading clinicians and medical researchers in India say they are aghast at the media reports that portray hand, foot and mouth disease (HFMD) — a common, relatively mild, viral infection afflicting children — as caused by a new virus responsible for what is dubbed as 'tomato flu'.

5 Sep 2022

Managing hazardous waste during the Covid-19 pandemic

In a hospital or medical environment, preventing and delaying the spread of Coronavirus goes far beyond washing hands. Good biosecurity is essential, and the safe disposal of infected waste will save lives.

From Inciner8 Limited 1 Apr 2022

Peptide-based vaccine fails to protect mice against SARS-CoV-2 despite T cell response

A recent study observed that peptide-based vaccination against SARS-CoV-2 failed to protect mice against COVID-19, albeit eliciting T cell responses.

28 Feb 2022

UK's fight against zoonotic diseases receives a £200 million boost

The UK's fight against zoonotic diseases, including avian flu and bovine tuberculosis received a major boost today (16 February) with the allocation of £200 million for a programme of investment into world leading research facilities.

15 Feb 2022

Complex RNA structures could have untapped therapeutic potential in the fight against COVID-19

To the untrained eye, the loops, kinks and folds in the single strand of RNA that makes up the coronavirus genome look like a jumble of spaghetti or tangled yarn. But to researchers like Amanda Hargrove, a chemistry professor at Duke University, the complex shapes that RNA takes on as it folds upon itself could have untapped therapeutic potential in the fight against COVID-19.

26 Nov 2021

Enterovirus 71 vaccine candidate strains exhibit good immunogenicity and cross-neutralization activity

Announcing a new article publication for Zoonoses journal. In this commentary researchers from Beijing Minhai Biotechnology Co., Ltd., Beijing, China, Hubei Provincial Center for Disease Control and Prevention, Wuhan, China, Guangdong Provincial Institute of Biological Products and Drugs, Guangzhou, China, Gaozhou Center for Disease Control and Prevention, Guangdong, China and the Yangchun Center for Disease Control and Prevention, Guangdong, China consider immungenicity and cross-neutralizing activity of enterovirus 71 vaccine candidate strains.

27 Sep 2021

Novel broad-spectrum antiviral compounds effective against Zika and SARS-CoV-2

A research team at the University of Alberta, Canada, led by Dr. Daniel Limonta, has described two novel molecules with broad antiviral properties that are effective against a range of virus types, including SARS-CoV-2.

21 May 2021